Ambulatory esophageal pH monitor

• US 4,632,119 A
• Filed: 10/23/1985
• Issued: 12/30/1986
• Est. Priority Date: 10/23/1985
• Status: Expired due to Term

• Current Assignee: Herman M. Finch University of Health Sciences
• Original Assignee: University Of Health Sciences The Chicago Medical School
• Inventors: Reichstein, Benjamin J.
• Primary Examiner(s): Howell, Kyle L.
• Assistant Examiner(s): Citrin, Randy
• Application Number:
  US06/790,359
• Time in Patent Office: 433 Days
• Field of Search: 128/630, 128/632, 128/636, 128/638, 128/670, 128/759, 436/163, 436/178
• US Class Current: 600/350
• CPC Class Codes: A61B 5/073 Intestinal transmitters
• CPC Class Codes: A61B 5/42 Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems A61B1/00, A61B5/4857, A61B5/486, A61B5/4866, A61B5/4869 take precedence
• CPC Class Codes: A61B 5/4233 oesophagus

Abstract

A unique ingestible and retrievable ambulatory esophageal monitor for colorimetric analysis of ambient pH within selected portions of the esophagus comprising a nasoesophgeal conduit at least one generally transparent semi-permeable envelope carried proximal the distal end of the conduit for positioning within the distal esophagus. The envelope contains an ion exchange color indicator composition comprised of a weak cation exchange substance selected from the group comprising a resin, a cellulose or an agarose and intermixed and bound therein being an indicator dye preferably either methylene blue or azure A. The ion exchange substance having a disassociation potential (pK) of at least 4 so that the indicator dye selectively disassociates causing the envelope to visually discolorize when exposed to a clinically significant ambient pH of 4 or less within the esophagus.

Claims

1. A self-contained diagnostic pH monitor for preliminary screening of gastroesophageal reflux disease and suitable for esophageal intubation without restriction of patient movement and activity, the monitor determining duration of exposure to pH levels clinically significant for gastroesophageal reflux disease, the monitor omitting use of external power, light and data processing sources, comprising:

a nasoesophageal probe for selected esophageal intubation, the probe having a length permitting positioning of a distal end of the probe proximal to the gastroesophageal junction of the esophagus;

at least one semipermeable envelope, the envelope being carried near the distal end of the probe, the envelope containing a composition including a cation exchange substance having an ionic dye bound thereto, the envelope being constructed of a material permeable to both hydronium ions and the ionic dye;

said composition substantially and irreversibly discoloring in response to extended exposure to a pH of 4 or less and upon withdrawal of the probe the composition in said envelope being colorimetrically analyzable to semi-quantitatively determine the duration of exposure to pH levels being clinically significant for preliminary screening of gastroesophageal reflux disease.

2. The pH monitor of claim 1 wherein the cationic exchange substance has a pK of at least 4.

3. The pH monitor of claim 2 wherein the cationic exchange substance has a pK of between 4 and 5.

4. The pH monitor of claim 1 wherein the cationic exchange substance is selected from the group consisting of a resin, a cellulose and an agarose.

5. The pH monitor of claim 1 wherein the ionic dye is selected from the group consisting of methylene blue and azure A.

6. The pH monitor of claim 1 further including a second semi-permeable envelope carried proximal to the one semi-permeable envelope, said second semi-permeable envelope being generally intermediately positioned along the probe.

7. The pH monitor of claim 1 wherein the probe includes a nasoesophageal catheter.